These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15450610)

  • 21. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
    Avila J; Wandosell F; Hernández F
    Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
    Miyasaka T; Sato S; Tatebayashi Y; Takashima A
    FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau therapeutic strategies for the treatment of Alzheimer's disease.
    Churcher I
    Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP
    Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argyrophilic grain disease.
    Ferrer I; Santpere G; van Leeuwen FW
    Brain; 2008 Jun; 131(Pt 6):1416-32. PubMed ID: 18234698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.
    Rankin CA; Sun Q; Gamblin TC
    Neurobiol Dis; 2008 Sep; 31(3):368-77. PubMed ID: 18588978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.
    Iqbal K; Gong CX; Liu F
    Expert Opin Ther Targets; 2014 Mar; 18(3):307-18. PubMed ID: 24387228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Tau Hyperphosphorylation
    Turab Naqvi AA; Hasan GM; Hassan MI
    Curr Top Med Chem; 2020; 20(12):1059-1073. PubMed ID: 31903881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.
    van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB
    Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
    Iqbal K; Grundke-Iqbal I
    J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
    Chatterjee S; Sang TK; Lawless GM; Jackson GR
    Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau, tangles, and Alzheimer's disease.
    Binder LI; Guillozet-Bongaarts AL; Garcia-Sierra F; Berry RW
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):216-23. PubMed ID: 15615640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.